Emilien Dugrand


Emilien is an Analyst at Gold Nest Capital, responsible for the evaluation of new technologies and products.

Emilien accumulated professional experiences in the health sector. Among his key experiences, Emilien worked at Servier Laboratories as a business developer in the Oncology Business Unit of the French subsidiary and in the Sales and Operations Department. He was a Self-Entrepreneur for one year in Paris, where he carried out operational consulting missions for both e-health start-ups and consumer healthcare laboratories. Emilien has an in-depth knowledge of city pharmacies and the hospital sector.

Emilien holds a PharmD in Pharmacy from the University of Montpellier in France, with a specialization in Industrial Pharmacy. His thesis in 2018 focused on access to the CAR-T cell therapy market in France.  In September 2019, he joined a Master of Science in Strategy and Management programme in International Business from ESSEC Business School in Singapore.

Emilien is native in French, fluent in English and Spanish.